tbuckley/cabot-search huggingface dataset:
Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells
Authors: Malika Hale, Taylor Mesojednik, Guillermo S. Romano Ibarra, Jaya Sahni, Alison Bernard, Karen Sommer, Andrew M. Scharenberg, David J. Rawlings, Thor A. Wagner
Journal: Molecular Therapy (2017)

The treatment or cure of HIV infection by cell and gene therapy has been a goal for decades. Recent advances in both gene editing and chimeric antigen receptor (CAR) technology have created new therapeutic possibilities for a variety of diseases. Broadly neutralizing monoclonal antibodies (bNAbs) with specificity for the HIV envelope glycoprotein provide a promising means of targeting HIV-infected cells. Here we show that primary human T cells engineered to express anti-HIV CARs based on bNAbs (HIVCAR) show specific activation and killing of HIV-infected versus uninfected cells in the absence of HIV replication. We also show that homology-directed recombination of the HIVCAR gene expression cassette into the CCR5 locus enhances suppression of replicating virus compared with HIVCAR expression alone. This work demonstrates that HIV immunotherapy utilizing potent bNAb-based single-chain variable fragments fused to second-generation CAR signaling domains, delivered directly into the CCR5 locus of T cells by homology-directed gene editing, is feasible and effective. This strategy has the potential to target HIV-infected cells in HIV-infected individuals, which might help in the effort to cure HIV. The treatment or cure of HIV infection by cell and gene therapy has been a goal for decades. Recent advances in both gene editing and chimeric antigen receptor (CAR) technology have created new therapeutic possibilities for a variety of diseases. Broadly neutralizing monoclonal antibodies (bNAbs) with specificity for the HIV envelope glycoprotein provide a promising means of targeting HIV-infected cells. Here we show that primary human T cells engineered to express anti-HIV CARs based on bNAbs (HIVCAR) show specific activation and killing of HIV-infected versus uninfected cells in the absence of HIV replication. We also show that homology-directed recombination of the HIVCAR gene expression cassette into the CCR5 locus enhances suppression of replicating virus compared with HIVCAR expression alone. This work demonstrates that HIV immunotherapy utilizing potent bNAb-based single-chain variable fragments fused to second-generation CAR signaling domains, delivered directly into the CCR5 locus of T cells by homology-directed gene editing, is feasible and effective. This strategy has the potential to target HIV-infected cells in HIV-infected individuals, which might help in the effort to cure HIV.
Quantitative Detection of NPM1 Mutations as Marker of Minimal Residual Disease (MRD) in the Large Majority of AML with Normal Karyotype.
Authors: Giuseppe Saglio, Paolo Gorello, Giovanni Cazzaniga, Enrico Gottardi, Maria Grazia Dell’Oro, Roberto Rosati, Giovanni Roti, Federica Alberti, Daniela Diverio, Massimo Fabrizio Martelli, Francesco Lo Coco, Andrea Biondi, Brunangelo Falini, Cristina Mecucci
Journal: Blood (2005)
Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome
Authors: J Li, M-H Duan, C Wang, X-F Huang, W Zhang, X-X Cao, T-N Zhu, J-L Zhuang, B Han, H Cai, H-C Cai, D-B Zhou
Journal: Leukemia (2017)
All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.
Authors: Richard F. Schlenk, Konstanze Doehner, Martina Kerz, Frank Hartmann, Francesco del Valle, Axel Glasmacher, Hans Pralle, Katharina Goetze, Elisabeth Koller, Guenther Gastl, Hans G. Mergenthaler, Hans Salwender, Heinz Kirchen, Detlef Haase, Stephan Kremers, Christoph Nerl, Matthias Theobald, Axel C. Matzdorff, Arnold Ganser, Hartmut Doehner
Journal: Blood (2005)
Evidence for Pulmonary Vascular Disease Despite Absence of Overt Pulmonary Arterial Hypertension (PAH) in Myeloproliferative Disorders (MPD) (PV and ET).
Authors: Jean-Jacques Kiladjian, Christine Lamberto, Thierry Laperche, Hilario Nunes, Hesham Mohamed, Dominique Valeyre, Jean-Paul Richalet, Pierre Fenaux
Journal: Blood (2005)
Seven day GP access may not be cost effective, auditors warn
Authors: Ingrid Torjesen
Journal: BMJ (2017)

Embargoed 00:01 WEDNESDAY 11 JANUARY 2017 

Ministers have failed to show evidence that plans to introduce seven day access to GPs are cost effective, the government’s national spending watchdog has warned.

The National Audit Office (NAO) said that the Department of Health and NHS England had not fully considered the consequences or the expense of their plans to offer evening and weekend access to all patients and provide 5000 extra GPs by 2020.1

In a new report, the NAO describes how pilot schemes run by NHS England had attempted to test patient demand for extended opening hours and determine how they should be provided. NHS England said that this was likely to involve hubs of local practices working together.

But the NAO said, “They have not yet …
Phase 1 Trial of Decitabine and Bortezomib in High Risk Acute Myeloid Leukemia (AML)
Authors: William Blum, Rebecca B. Klisovic, Ramiro Garzon, Alison Walker, Sebastian Schwind, Shujun Liu, Larry Schaaf, Celia Garr, Steven M. Devine, Michael R. Grever, John C. Byrd, Guido Marcucci
Journal: Blood (2010)
A Methylation Profile of Tumor Suppressor Genes Predicts a Poorer Survival in Patients with Refractory Anemia with Ringed Sideroblasts.
Authors: Ana Valencia, Jose Cervera, Esperanza Such, Esther Gamero, Mariam Ibañez, Silvestre Oltra, Maria Leonor Senent, Amparo Sempere, Federico Gomis, Maria Luz Perez-Sirvent, Miguel Sanz, Guillermo Sanz
Journal: Blood (2009)
The Negative Impact of Underweight and Weight Loss on Survival of Children with Acute Lymphoblastic Leukemia
Authors: Marissa den Hoed, S.M.F. Pluijm, Hester A. de Groot-Kruseman, Mariël L. Te Winkel, Erica L.T. van den Akker, Peter M. Hoogerbrugge, Henk van den Berg, J.a. Leeuw, Marrie Bruin, Dorine Bresters, A.J.P. Veerman, Marta Fiocco, Rob Pieters, Marry M. van den Heuvel-Eibrink
Journal: Blood (2014)
A GCH1 Haplotype Associated with Susceptibility to Vasoocclusive Pain and Impaired Vascular Function in Sickle Cell Anemia.
Authors: James G Taylor, Inna Belfer, Krupa Desai, Victoria Youngblood, Lita A. Freeman, Deepika S. Darbari, Gregory J. Kato, Jacqueline N. Milton, Stephen W Hartley, Martin H Steinberg, David Goldman, Mitchell B Max
Journal: Blood (2009)
Identification of RHAMM-Derived CD8+ Restricted, Heteroclitical, Cryptic Epitope R9Y as a Promising Target for Immunotherapy of Chronic Lymphocytic Leukemia.
Authors: Krzysztof Giannopoulos, Anna Dmoszynska, Jacek Rolinski, Jochen Greiner, Stephan Stilgenbauer, Michael Schmitt
Journal: Blood (2009)
Reduced HMOX1 Expression in Myelomatous Bones Is Associated with Poor Survival and Its Induction Regulates Osteoclastogenesis and Osteoblastogenesis
Authors: Xin Li, Qing Zhang, Sarah K. Johnson, Wen Ling, Sharmin Khan, Frits van Rhee, Saad Z Usmani, Sarah Waheed, Bart Barlogie, Joshua Epstein, Shmuel Yaccoby
Journal: Blood (2012)
The Registro Italiano Trombocitemie (GIMEMA Project): Preliminary Analysis of the First 801 Enrolled Patients.
Authors: Luigi Gugliotta, Alessia Tieghi, Gianluca Gaidano, Silvia Franceschetti, Giorgina Specchia, Paola Carluccio, Maria Gabriella Mazzucconi, Cristina Santoro, Alfredo Dragani, Rosanna Ciancia, Anna Candoni, Fausto Palmieri, Elisa Rumi, Elisabetta Antonioli, Maria Rosaria Villa, Daniela Cilloni, Augusto Federici, Nicola Vianelli, Franca Radaelli, Maria Luigia Randi, Potito Scalzulli, Lorella Melillo, Emma Cacciola, Rossella Cacciola, Marco Gobbi
Journal: Blood (2006)
Phase I Trial of Everolimus and Rituximab or Everolimus, Bortezomib and Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia
Authors: Irene M. Ghobrial, Erica N Boswell, Ranjit Banwait, Tiffany Poon, Amanda Donovan, Stacey Chuma, Janet Kunsman, Diane Warren, Meghan Bagshaw, Kenneth C. Anderson, Paul G. Richardson, Steven Treon
Journal: Blood (2011)
National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
Authors: Andrea Hauser, Alexandra Hofmann, Kirsten Hanke, Viviane Bremer, Barbara Bartmeyer, Claudia Kuecherer, Norbert Bannert
Journal: Eurosurveillance (2017)

To enable an up-to-date molecular analysis of human immunodeficiency virus (HIV) genotypes circulating in Germany we have established a surveillance system based on recently acquired HIV infections. New HIV infections are reported to the Robert Koch Institute as a statutory duty for anonymous notification. In 2013 and 2014, a dried serum spot (DSS) sample was received from 6,371 newly diagnosed HIV-cases; their analysis suggested that 1,797 samples originated from a recent infection. Of these, 809 were successfully genotyped in the pol region to identify transmitted drug resistance (TDR) mutations and to determine the HIV-1 subtype. Total TDR was 10.8%, comprising 4.3% with mono-resistance to nucleoside reverse transcriptase inhibitors (NRTIs), 2.6% to non-NRTIs, 3.0% to protease inhibitors and 0.6% and 0.2%, respectively, with dual- and triple-class resistances. HIV-1 subtype B was most prevalent with 77.0%. Non-B infections were identified more often in men and women with heterosexual transmission compared with intravenous drug users or men who have sex with men (79% and 76%, 33%, 12%; all p &lt; 0.05). Non-B subtypes were also more frequently found in patients originating from countries other than Germany (46% vs 14%; p &lt; 0.05) and in patients infected outside of Germany (63% vs 14%; p &lt; 0.05).
Evaluation of nausea, vomiting, and diarrhea in oncologic patients at the emergency department
Authors: A. I. Ferrer Perez, M. J. Vidal Losada, S. Serrano Solares, M. Tobeña Puyal, I. Pajares Bernad, D. Lopez Sanchez, M. Ruiz-Echarri Rueda, E. Millastre Bocos, J. Lambea Sorrosal, A. Tres Sanchez
Journal: Journal of Clinical Oncology (2009)

e20727 Background: Nausea, vomiting, and diarrhea are very common in cancer patients under palliative treatment. These usually can be controlled on an outpatient basis, although they can become extremely debilitating for the patient. It is not uncommon that patients come to the emergency department because of the rebelliousness of these symptoms. The aim of this study is to describe cancer patient population which consults for nausea, vomiting, or diarrhea in the Emergency Department (ED) of a tertiary hospital, their causes and clinical management. Methods: From October 2007 to October 2008, all cancer patients attended at the Emergency Department of our hospital were prospectively collected. The reasons for consultation, diagnosis and clinical management in the SE are described Results: Of 560 patients enrolled, 440 patients were stage IV disease. 54.8% of them ( 307 patients) were under palliative chemotherapy treatment at the time of consultation. 5.9% consulted for nausea or vomiting (33 patients), 3.6% (20 patients) consulted for diarrhea, 0.7% (4 patients) consulted for both. 57.5% of patients (19 patients) with nausea or vomiting, 90% (18 patients) with diarrhea and 100% (4 patients) with both symptoms were receiving chemotherapy at that moment. The most frequent causes of these symptoms were chemotherapy toxicity (52.6%) and acute abdominal pathology (15.8%). 24 patients (72.7%%) who consulted for nausea or vomiting, 12 patients (60%) who consulted for diarrhea and 3 patients (75%) who consulted for vomiting and diarrhea required at least 24 hours of hospitalization. Conclusions: Vomiting and diarrhea are very prevalent symptoms in oncology patients, but they are not frequent causes of demanding emergency attention. The most important etiology of these situations is the chemotherapy toxicity, followed by acute abdominal pathology. Most patients attended in ED because of these symptoms require hospitalization. No significant financial relationships to disclose.
Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update
Authors: Bertrand Coiffier, Barbara Pro, Miles Prince, Francine M. Foss, Lubomir Sokol, Matthew Greenwood, Dolores Caballero, Franck Morschhauser, Martin Wilhelm, Lauren Pinter-Brown, Swaminathan Padmanabhan, Andrei R. Shustov, Tina Nielsen, Jean Nichols, Julie Wolfson, Barbara E Balser, Steven M. Horwitz
Journal: Blood (2012)
Single Nucleotide Polymorphism of CC Chemokine Ligand 5 Promoter Gene in Recipient May Affect on the Development of Chronic Graft-Versus-Host Disease and Its Severity after Allogeneic Transplantation.
Authors: Dong Hwan Kim, Sang Kyun Sohn, John Kuruvilla, Vikas Gupta, Jeffrey Lipton, Hans Messner
Journal: Blood (2006)
Vancomycin-Associated Cast Nephropathy
Authors: Yosu Luque, Kevin Louis, Chantal Jouanneau, Sandrine Placier, Emmanuel Esteve, Dominique Bazin, Eric Rondeau, Emmanuel Letavernier, Alice Wolfromm, Clément Gosset, Anna Boueilh, Maren Burbach, Perrine Frère, Marie-Christine Verpont, Sophie Vandermeersch, Dominique Langui, Michel Daudon, Vincent Frochot, Laurent Mesnard
Journal: Journal of the American Society of Nephrology (2017)

Vancomycin is a widely prescribed antibiotic, but the exact nature of vancomycin-associated nephrotoxicity is unclear, in particular when considering the frequent coadministration of aminoglycosides. We describe here the initial case of a 56-year-old woman with normal renal function developing unexplained ARF without hypovolemia after administration of vancomycin without coadministration of aminoglycosides. Studying the patient’s renal biopsy specimen, we ascertained that obstructive tubular casts composed of noncrystal nanospheric vancomycin aggregates entangled with uromodulin explained the vancomycin-associated ARF. We developed in parallel a new immunohistologic staining technique to detect vancomycin in renal tissue and confirmed retrospectively that deleterious vancomycin-associated casts existed in eight additional patients with acute tubular necrosis in the absence of hypovolemia. Concomitant high vancomycin trough plasma levels had been observed in each patient. We also reproduced experimentally the toxic and obstructive nature of vancomycin-associated cast nephropathy in mice, which we detected using different in vivo imaging techniques. In conclusion, the interaction of uromodulin with nanospheric vancomycin aggregates represents a new mode of tubular cast formation, revealing the hitherto unsuspected mechanism of vancomycin-associated renal injury.
Trisomy 21 Expands the Megakaryocyte-Erythroid Progenitor Compartment in Human Fetal Liver-Implications for Down Syndrome AMKL.
Authors: Oliver Tunstall-Pedoe, Josu de la Fuente, Phillip R. Bennett, Nicholas M. Fisk, Paresh Vyas, Irene A.G. Roberts
Journal: Blood (2006)
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non–Small Cell Lung Cancer
Authors: Jessica J. Lin, Lauren L. Ritterhouse, Siraj M. Ali, Mark Bailey, Alexa B. Schrock, Justin F. Gainor, Lorin A. Ferris, Mari Mino-Kenudson, Vincent A. Miller, Anthony J. Iafrate, Jochen K. Lennerz, Alice T. Shaw
Journal: Journal of Thoracic Oncology (2017)
Deoxyadenosine Inhibits T-Cell Activation in ADA-SCID Patients through a cAMP/PKA-Dependent Pathway.
Authors: Barbara Cassani, Massimiliano Mirolo, Federica Cattaneo, Ulrike Benninghoff, Filippo Carlucci, Antonella Tabucchi, Claudio Bordignon, Maria Grazia Roncarolo, Alessandro Aiuti
Journal: Blood (2006)
Improved Sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in Quantifying the Extent of Bone Marrow Involvement in Patients with Multiple Myeloma (MM).
Authors: Sikander Ailawadhi, Lyudmyla Derby, Kena C. Miller, Terry L. Mashtare, Gregory Wilding, Swaminathan Padmanabhan, Ronald Gottlieb, Ronald A. Alberico, Donald L. Klippenstein, Ahmed N. Abdelhalim, Asher A. Chanan-Khan
Journal: Blood (2007)
Treatment of New Cases of Acute Promyelocytic Leukaemia by Arsenic Trioxide.
Authors: Ardeshir Ghavamzadeh, Kamran Alimoghaddam, Hamidolah Ghaffari, Shahrano Rostami, Yousef Mortazavi, Asadolah Mousavi, Mehrangiz Tootonchi, Mohamad Jahani, Roholah Hosseini, Masoud Iravani, Babak Bahar, Nasser Aghdami
Journal: Blood (2004)
Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses
Authors: Abhishek Das, Balthasar A. Heesters, Allison Bialas, Joseph O’Flynn, Ian R. Rifkin, Jordi Ochando, Nanette Mittereder, Gianluca Carlesso, Ronald Herbst, Michael C. Carroll
Journal: Immunity (2017)
Maternity units face challenging workforce gaps, MPs are told
Authors: Adrian O’Dowd
Journal: BMJ (2017)

The number of midwives joining the NHS is starting to “flat-line” and fewer doctors are working in maternity units, MPs have been told.

Too many newly qualified midwives either choose not to work in the NHS or cannot find jobs, expert witnesses told MPs on the parliamentary health committee during an evidence session on 17 January for its inquiry into maternity services.

MPs asked what the biggest risks and challenges were in implementing the recommendations made in the national maternity review report Better Births ,1 commissioned by NHS England and published last year.

Cathy Warwick, chief executive of the Royal College of Midwives, giving evidence, said, “While we are training …
Cytology from endoscopic retrograde cholangiopancreatography in the evaluation of invasive pancreatic head intraductal papillary mucinous neoplasm: A necessity?
Authors: Alexandra M Roch, Michael Garrett House, Neil R Sharma, Jessica L Cioffi, John M DeWitt, Jeffrey J Easler, Eugene P Ceppa, Nicholas J Zyromski, Attila Nakeeb, C. Max Schmidt
Journal: Journal of Clinical Oncology (2015)

266 Background: Endoscopic retrograde cholangiopancreatography (ERCP) with brushing/fluid sampling has historically been the standard to establish invasive transformation of pancreatic head intraductal papillary mucinous neoplasm (IPMN). More recently, endoscopic ultrasound (EUS) with fine needle aspiration (FNA) has been employed for this purpose. We hypothesized that for patients with invasive IPMN, in the era of EUS FNA, there is no additional benefit of ERCP brushing/fluid sampling. Methods: A retrospective review of a prospectively maintained database of patients who underwent surgical resection for IPMN at a single academic center (1992-2014) was performed. Patients with invasive pancreatic head IPMN on surgical pathology were included. Cytopathology was considered positive if it showed adenocarcinoma or markedly atypical cells. Results: Of the 74 patients with invasive IPMN, 55 had a pancreatic head neoplasm. Preoperatively, 4 patients had neither EUS nor ERCP, 27 had only 1 endoscopic study (ERCP n=16, EUS n=11), and 24 had both EUS and ERCP. In 11 patients with EUS, 8 had positive FNA (73% sensitivity for cancer detection). In 16 patients with ERCP (brushing n=7, fluid n=9), 5 had positive cytology resulting in 31% sensitivity. Further analysis revealed 29% and 33% sensitivity for brushing and fluid sampling, respectively. When both procedures were performed (n=24; EUS+ERCP fluid n=10, EUS+ERCP brushing n=14), the sensitivity was 75%, but ERCP cytology changed the diagnosis in only 2 patients. EUS FNA was performed regardless of ERCP cytology results in 18 patients (after brushing n=6, after fluid sampling n=4, same day n=8; median interval=4 days). 6 patients had negative cytology from both EUS and ERCP. Conclusions: In patients with invasive pancreatic head IPMN, sensitivity of ERCP cytology for cancer detection was poor (31%), making an impact on diagnosis in only 2/55 patients. EUS FNA was performed in 75% patients regardless of ERCP cytology results. Aside from the therapeutic impact of ERCP (biliary endoprosthesis in jaundiced patients), its cytological role is limited, resulting in unnecessary and potentially avoidable cost.
Real-Life Analysis of Dasatinib in Chronic Phase CML Patients Aged &gt; 60 Years Resistant/Intolerant to Imatinib.
Authors: Roberto Latagliata, Massimo Breccia, Fabio Stagno, Luigiana Luciano, Antonella Gozzini, Fausto Castagnetti, Mario Annunziata, Silvia De Matteis, Francesco Albano, Stefano Ulisciani, Patrizia Pregno, Raffaele Porrini, Elisabetta Abruzzese, Bruno Martino, Mario Tiribelli, Pellegrino Musto, Paolo Avanzini, Antonella Russo Rossi, Simona Sica, Umberto Vitolo, Enrico Montefusco, Giovanna Rege Cambrin, Felicetto Ferrara, Gianantonio Rosti, Valeria Santini, Fabrizio Pane, Francesco Di Raimondo, Giuliana Alimena
Journal: Blood (2009)
Impact of Comorbidities on Early and Late Mortalities After Allogeneic Hematopoietic Cell Transplantation (HCT)
Authors: Mohamed L. Sorror, Rainer Storb, Brenda M. Sandmaier, Smita Bhatia, Richard T. Maziarz, Michael A. Pulsipher, Michael T. Maris, H. Joachim Deeg, Frederick R. Appelbaum, David G. Maloney, Paul J Martin, Barry Storer
Journal: Blood (2011)
Pulmonary Hypertension in Sickle Cell Disease: The Role of Activated Blood Coagulation and Inflammation.
Authors: Kenneth I. Ataga, Charity Moore, Susan Jones, Oludamilola Olajide, Cathy Sohier, Shantres Clark, Herbert C. Whinna, Leslie V. Parise, Alan Hinderliter, Eugene P. Orringer
Journal: Blood (2005)
TCT-118 A Multidisciplinary, Multimodality, But Minimalist (3M) Approach To Transfemoral Transcatheter Aortic Valve Replacement Facilitates Safe Next Day Discharge In High Risk Patients
Authors: David A. Wood, Rohan S. Poulter, Richard Cook, Sandra Lauck, Philippe Genereux, Iefan Lim, Nigussie Bogale, Ronald K. Binder, Marco Barbanti, Danny Dvir, Melanie Freeman, Mathieu Lempereur, Imran Shiekh, John Tan, John Jue, Ken Gin, P.K. Lee, Parvathy Nair, Teresa S. Tsang, Jonathon K. Todd, Anson Cheung, Jian (James) Ye, Jonathon A. Leipsic, David Cohen, Martin Leon, Webb John
Journal: Journal of the American College of Cardiology (2013)
Coagulation Profile As Prognostic Indicator in Acute Myeloid Leukemia,
Authors: Francisca C. Gushiken, Yen Dai Vo, Lianchun Xiao, Tapan Kadia, Jorge E. Cortes, Naveen Pemmaraju, Sherry Pierce, Hagop M. Kantarjian, Gautam Borthakur
Journal: Blood (2011)
IMPS-16MESENCHYMAL TYPE GLIOMA STEM CELL EXPRESS ICOS LIGAND AND UPREGULATE ICOS<sup>+</sup>IL-10<sup>+</sup>T CELLS
Authors: Ryoichi Iwata, Tomoki Ito, Muneo Inaba, Taro Koike, Hideyuki Oshige, Kunikazu Yoshimura, Masahiro Nonaka, Hisao Yamada, Shosaku Nomura, Umberto Dianzani, Ichiro Nakano, Akio Asai
Journal: Neuro-Oncology (2015)

Tumor heterogeneity of high-grade glioma (HGG) is recognized by four Overall survival
Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning in the Patients with Acute Leukemia
Authors: Hyun-Kyung Kim, Yeung-Chul Mun, Eun-Sun Yoo, Kyoung Eun Lee, Eunmi Nam, Soon Nam Lee, Chu-Myong Seong
Journal: Blood (2011)